[Perioperative short-term prevention of puerperal infections following cesarean section with metronidazole].
A prospective randomised placebo-controlled clinical study showed that it was not possible to reduce the infectious morbidity following Caesarean section by one perioperative intravenous infusion of 500 mg metronidazole. Of all the 219 patients the endometritis rate was 6%, the wound infection rate 6% and the puerperal sepsis rate 2%.
D002585:Cesarean Section; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use*; D011247:Pregnancy; D011645:Puerperal Infection / Q000517:prevention & control*; D018805:Sepsis / Q000517:prevention & control; D013530:Surgical Wound Infection / Q000517:prevention & control
D008795:Metronidazole
Perioperative Kurzzeitprophylaxe der Puerperalinfektionen nach Kaiserschnitt mit Metronidazol.